SR17018 NEW
| Price | $54 | $89 | $188 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-10 |
Product Details
| Product Name: SR17018 | CAS No.: 2134602-45-0 |
| Purity: 99.89% | Supply Ability: 10g |
| Release date: 2025/11/10 |
Product Introduction
Bioactivity
| Name | SR17018 |
| Description | SR17018, a mu-opioid receptor (MOR) agonist, binds with GTPγS and has an EC50 of 97 nM. |
| In vitro | SR17018 acts as an agonist at the mu-opioid receptor (MOR), exhibiting binding affinity with GTPγS, demonstrated by an EC50 value of 97 nM. It does not significantly induce βarrestin2 recruitment to the MOR at concentrations below 10 μM, suggesting its mechanism of action primarily involves signaling through G proteins rather than βarrestin2 pathways. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.43 mM), Sonication is recommended. DMSO : 4.11 mg/mL (10 mM), Sonication and heating are recommended. |
| Keywords | μ-opioid receptor | SR-17018 | SR17018 | SR 17018 | OpioidReceptor | Opioid Receptor | Inhibitor | inhibit |
| Inhibitors Related | Docusate sodium | Bevenopran | Mirtazapine | (-)-Menthol | SCH 221510 | Naltrexone hydrochloride | Progesterone | Meptazinol hydrochloride | Trimebutine | Mianserin hydrochloride | Amentoflavone | Trimebutine maleate |
| Related Compound Libraries | Target-Focused Phenotypic Screening Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Pain-Related Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | Anti-Parkinson's Disease Compound Library | NO PAINS Compound Library | Endocrinology-Hormone Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/25kg |
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-11-24 | |
| $0.00/1BOX |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-09-05 | |
| $1.50/1g |
VIP4Y
|
Shaanxi Didu New Materials Co. Ltd
|
2025-06-25 | |
| $0.00/1g |
VIP1Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2025-04-16 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY